These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7788624)
41. Peripheral hormonal responses to D-fenfluramine as a probe of central serotonergic function in humans. Abel KM; Cleare AJ Psychopharmacology (Berl); 1999 Feb; 142(1):68-72. PubMed ID: 10102784 [TBL] [Abstract][Full Text] [Related]
42. Neuroendocrine aspects of chronic fatigue syndrome. Papanicolaou DA; Amsterdam JD; Levine S; McCann SM; Moore RC; Newbrand CH; Allen G; Nisenbaum R; Pfaff DW; Tsokos GC; Vgontzas AN; Kales A Neuroimmunomodulation; 2004; 11(2):65-74. PubMed ID: 14758052 [TBL] [Abstract][Full Text] [Related]
43. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Mintzer J; Brawman-Mintzer O; Mirski DF; Unger R; Nietert P; Meeks A; Sampson R Biol Psychiatry; 1998 Nov; 44(9):918-21. PubMed ID: 9807649 [TBL] [Abstract][Full Text] [Related]
44. Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Cleare AJ; Murray RM; O'Keane V Psychopharmacology (Berl); 1997 Dec; 134(4):406-10. PubMed ID: 9452184 [TBL] [Abstract][Full Text] [Related]
45. Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men. Goodwin GM; Murray CL; Bancroft J J Affect Disord; 1994 Feb; 30(2):117-22. PubMed ID: 8201126 [TBL] [Abstract][Full Text] [Related]
46. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Cleare AJ; McGregor A; O'Keane V Clin Endocrinol (Oxf); 1995 Dec; 43(6):713-9. PubMed ID: 8736274 [TBL] [Abstract][Full Text] [Related]